ARS Pharmaceuticals Statistics
Total Valuation
SPRY has a market cap or net worth of $776.01 million. The enterprise value is $699.54 million.
Important Dates
The last earnings date was Monday, March 9, 2026, before market open.
| Earnings Date | Mar 9, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SPRY has 99.30 million shares outstanding. The number of shares has decreased by -3.74% in one year.
| Current Share Class | 99.30M |
| Shares Outstanding | 99.30M |
| Shares Change (YoY) | -3.74% |
| Shares Change (QoQ) | +0.22% |
| Owned by Insiders (%) | 9.45% |
| Owned by Institutions (%) | 55.32% |
| Float | 41.56M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 9.21 |
| Forward PS | 4.82 |
| PB Ratio | 6.79 |
| P/TBV Ratio | 7.78 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 8.30 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.28, with a Debt / Equity ratio of 1.47.
| Current Ratio | 7.28 |
| Quick Ratio | 6.93 |
| Debt / Equity | 1.47 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -69.05 |
Financial Efficiency
Return on equity (ROE) is -92.33% and return on invested capital (ROIC) is -535.37%.
| Return on Equity (ROE) | -92.33% |
| Return on Assets (ROA) | -33.04% |
| Return on Invested Capital (ROIC) | -535.37% |
| Return on Capital Employed (ROCE) | -62.20% |
| Weighted Average Cost of Capital (WACC) | 7.25% |
| Revenue Per Employee | $517,043 |
| Profits Per Employee | -$1.05M |
| Employee Count | 163 |
| Asset Turnover | 0.25 |
| Inventory Turnover | 4.95 |
Taxes
| Income Tax | -80,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -37.43% in the last 52 weeks. The beta is 0.78, so SPRY's price volatility has been lower than the market average.
| Beta (5Y) | 0.78 |
| 52-Week Price Change | -37.43% |
| 50-Day Moving Average | 9.25 |
| 200-Day Moving Average | 11.57 |
| Relative Strength Index (RSI) | 39.30 |
| Average Volume (20 Days) | 1,640,257 |
Short Selling Information
The latest short interest is 23.72 million, so 23.89% of the outstanding shares have been sold short.
| Short Interest | 23.72M |
| Short Previous Month | 22.75M |
| Short % of Shares Out | 23.89% |
| Short % of Float | 57.07% |
| Short Ratio (days to cover) | 21.17 |
Income Statement
In the last 12 months, SPRY had revenue of $84.28 million and -$171.30 million in losses. Loss per share was -$1.74.
| Revenue | 84.28M |
| Gross Profit | 50.67M |
| Operating Income | -179.45M |
| Pretax Income | -171.38M |
| Net Income | -171.30M |
| EBITDA | -178.08M |
| EBIT | -179.45M |
| Loss Per Share | -$1.74 |
Full Income StatementBalance Sheet
The company has $244.99 million in cash and $168.51 million in debt, with a net cash position of $76.47 million or $0.77 per share.
| Cash & Cash Equivalents | 244.99M |
| Total Debt | 168.51M |
| Net Cash | 76.47M |
| Net Cash Per Share | $0.77 |
| Equity (Book Value) | 114.26M |
| Book Value Per Share | 1.15 |
| Working Capital | 245.75M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$170.87 million and capital expenditures -$339,000, giving a free cash flow of -$171.21 million.
| Operating Cash Flow | -170.87M |
| Capital Expenditures | -339,000 |
| Depreciation & Amortization | 1.37M |
| Net Borrowing | 96.26M |
| Free Cash Flow | -171.21M |
| FCF Per Share | -$1.72 |
Full Cash Flow StatementMargins
Gross margin is 60.13%, with operating and profit margins of -212.92% and -203.25%.
| Gross Margin | 60.13% |
| Operating Margin | -212.92% |
| Pretax Margin | -203.35% |
| Profit Margin | -203.25% |
| EBITDA Margin | -211.30% |
| EBIT Margin | -212.92% |
| FCF Margin | n/a |
Dividends & Yields
SPRY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 3.74% |
| Shareholder Yield | 3.74% |
| Earnings Yield | -22.07% |
| FCF Yield | -22.06% |
Analyst Forecast
The average price target for SPRY is $40.00, which is 411.84% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $40.00 |
| Price Target Difference | 411.84% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 56.13% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SPRY has an Altman Z-Score of 1.58 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.58 |
| Piotroski F-Score | 1 |
